On the heels of the announcement that consumer wearable Fitbit is adding a relative SpO2 sensor to its Fitbit Ionic smart watch, the company this week announces that it is collaborating with DexCom Inc to develop and market products to help people better manage their diabetes and get a more complete picture of their overall health with easy-to-use mobile tools.
The first planned initiative is to bring Dexcom CGM data to Fitbit’s new smartwatch, Fitbit Ionic. Through this experience, Dexcom CGM users on either Android or iOS devices would be able to see both activity and glucose levels, right on their wrist.
“The strength of our brand and our ability to track critical health metrics continuously for up to 4+ days, coupled with Dexcom’s market leadership in CGM [continuous glucose monitoring], present a powerful combination that we hope will help millions of people better manage their diabetes,” says James Park, CEO of Fitbit, in a release. “With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users.”
The companies are targeting availability as soon as possible in 2018 and will continue to explore opportunities to work together to develop tools and resources aimed at helping people better manage their diabetes.
